Literature DB >> 18406979

HIV infection and complications in emergency medicine.

Catherine A Marco1, Richard E Rothman.   

Abstract

HIV infection is a common worldwide public health challenge affecting an estimated 40 million persons. In the United States, there have been over 900,000 cases of AIDS, and it is estimated that there are currently over 1 million HIV-infected persons in the United States. Although the population of HIV seropositivity is concentrated in large urban settings, infections have been documented in all states. Because of the widespread prevalence and serious health consequences, it is imperative that the emergency physician be knowledgeable and skilled to diagnose and manage HIV-related emergency conditions. Knowledge of clinical presentations, differential diagnosis, early treatment strategies, and disposition options is crucial to the effective emergency department management of HIV infections and AIDS.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18406979     DOI: 10.1016/j.emc.2008.01.001

Source DB:  PubMed          Journal:  Emerg Med Clin North Am        ISSN: 0733-8627            Impact factor:   2.264


  3 in total

1.  Minding the Prevention Protocol for Blood-Borne Diseases via EM Residents.

Authors:  Soad Mahfoozpour; Alireza Baratloo; Hamidreza Hatamabadi; Kiandokht Karimian; Saeed Safari
Journal:  Trauma Mon       Date:  2013-05-26

2.  Spontaneous Pneumomediastinum, Pneumopericardium, and Pneumothorax with Respiratory Failure in a Patient with AIDS and Pneumocystis jirovecii Pneumonia.

Authors:  Yun Kyung Park; Hee Chan Jung; Shin Young Kim; Min Young Kim; Kwanhoon Jo; Se Young Kim; Borami Kang; Gihyeon Woo; Hyun Joo Choi; Seong-Heon Wie
Journal:  Infect Chemother       Date:  2014-09-24

3.  Cardiovascular disease in human immunodeficiency virus-infection as a cause of hospitalization: a case-series in a General Hospital in Peru.

Authors:  Germán Valenzuela-Rodríguez; Edward Mezones-Holguín; Fernando Mendo-Urbina; Alfonso J Rodríguez-Morales
Journal:  Braz J Infect Dis       Date:  2015-04-16       Impact factor: 3.257

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.